Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age5-12
SponsorOhio State University
This study seeks to determine whether glasses prescriptions determined from computer analysis of detailed images of the eyes provide better vision outcomes for children with Down syndrome than prescriptions determined using routine clinical methods.
Down syndrome
Age 5 to 12 years
Ability to sit for study measures
Able to be dilated
Nystagmus
History of Ocular or Refractive Surgery
Corneal or lenticular opacities
Ocular disease
Ohio State University
Lead sponsor
National Eye Institute (NEI)
Collaborator